West Pharmaceutical Services, Inc. logo
WSTWest Pharmaceutical Services, Inc.

EV/Assets Ratio: 6.13x

Is the EV/Assets ratio high or low?

The EV/Assets ratio of 6.13x is in line with its 5-year average of 6.71x, near the low end of its 5-year range (3.80x–12.00x).

As of Saturday, June 27, 2026. 32.19% above its 12-month average of 4.64x.

WST EV/Assets Ratio

WST EV/Assets Ratio Chart

6.13x
+39.64% 1Y
WST EV/Assets Ratio

WST Average EV/Assets Ratio Chart

WST EV/Assets Ratio

WST Current vs Average EV/Assets Ratio Chart

WST EV/Assets Ratio Metrics

EV/ASSETS RATIO

6.13x

EV/ASSETS RATIO AVG TTM

4.64x

EV/ASSETS RATIO AVG 3Y

5.88x

EV/ASSETS RATIO AVG 5Y

6.58x

EV/ASSETS RATIO AVG 10Y

5.92x

EV/ASSETS RATIO AVG 15Y

4.61x

EV/ASSETS RATIO AVG 20Y

3.76x

CURRENT VS TTM AVG

+32.19%

CURRENT VS 3Y AVG

+4.30%

CURRENT VS 5Y AVG

-6.77%

CURRENT VS 10Y AVG

+3.52%

CURRENT VS 15Y AVG

+33.11%

CURRENT VS 20Y AVG

+62.86%

WST Competitors' EV/Assets Ratio

NAMEMARKET CAPEV/ASSETS RATIOTTM3Y5Y
West Pharmaceutical Services, Inc. (WST)$24.79B6.13x4.64x5.88x6.58x
Waters Corporation (WAT)vs ›$24.41B1.46x3.98x4.50x5.42x
Mettler-Toledo International Inc. (MTD)vs ›$25.44B7.47x8.22x8.60x9.30x
Quest Diagnostics Incorporated (DGX)vs ›$23.08B1.78x1.68x1.57x1.58x
BioNTech SE (BNTX)vs ›$23.07B0.49x0.54x0.54x1.29x
United Therapeutics Corporation (UTHR)vs ›$23.03B3.65x2.76x2.19x2.08x
Moderna, Inc. (MRNA)vs ›$26.69B2.26x1.19x1.48x2.48x
DexCom, Inc. (DXCM)vs ›$26.76B4.11x4.19x5.81x7.42x
Incyte Corporation (INCY)vs ›$22.73B2.74x2.53x2.15x2.46x
Labcorp Holdings Inc. (LH)vs ›$22.26B1.51x1.57x1.46x1.38x

EV/Assets Ratio Formula & Definition

EV/Assets compares enterprise value to total assets. It is useful for asset-heavy businesses and for comparing how much the market pays for each dollar of assets.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

EV/Assets Ratio FAQ

What is the EV/Assets ratio for West Pharmaceutical Services, Inc. (WST)?
The EV/Assets ratio for WST stock is 6.13x.
Is West Pharmaceutical Services, Inc.'s EV/Assets ratio high or low?
The EV/Assets ratio of 6.13x is in line with its 5-year average of 6.71x, near the low end of its 5-year range (3.80x–12.00x).
What is the TTM average EV/Assets ratio for West Pharmaceutical Services, Inc. (WST)?
The TTM average EV/Assets ratio for WST stock is 4.64x.
What is the 3Y average EV/Assets ratio for West Pharmaceutical Services, Inc. (WST)?
The 3Y average EV/Assets ratio for WST stock is 5.88x.
What is the 5Y average EV/Assets ratio for West Pharmaceutical Services, Inc. (WST)?
The 5Y average EV/Assets ratio for WST stock is 6.58x.
What is the 10Y average EV/Assets ratio for West Pharmaceutical Services, Inc. (WST)?
The 10Y average EV/Assets ratio for WST stock is 5.92x.
What is the 15Y average EV/Assets ratio for West Pharmaceutical Services, Inc. (WST)?
The 15Y average EV/Assets ratio for WST stock is 4.61x.
What is the 20Y average EV/Assets ratio for West Pharmaceutical Services, Inc. (WST)?
The 20Y average EV/Assets ratio for WST stock is 3.76x.

WST EV/Assets Ratio History

DATEEV/ASSETS RATIO
2026-06-266.13x
2026-06-256.06x
2026-06-245.95x
2026-06-235.88x
2026-06-225.76x
2026-06-185.73x
2026-06-175.65x
2026-06-165.76x
2026-06-155.79x
2026-06-125.74x
2026-06-115.77x
2026-06-105.78x
2026-06-095.85x
2026-06-085.58x
2026-06-055.49x
2026-06-045.54x
2026-06-035.52x
2026-06-025.45x
2026-06-015.52x
2026-05-295.64x
2026-05-285.62x
2026-05-275.46x
2026-05-265.52x
2026-05-225.52x
2026-05-215.52x
2026-05-205.33x
2026-05-195.30x
2026-05-185.31x
2026-05-155.29x
2026-05-145.24x
2026-05-135.28x
2026-05-125.45x
2026-05-115.63x
2026-05-085.69x
2026-05-075.62x
2026-05-065.46x
2026-05-055.41x
2026-05-045.24x
2026-05-015.25x
2026-04-305.19x
2026-04-295.15x
2026-04-285.10x
2026-04-275.27x
2026-04-245.34x
2026-04-235.41x
2026-04-224.56x
2026-04-214.57x
2026-04-204.62x
2026-04-174.55x
2026-04-164.48x
2026-04-154.43x
2026-04-144.45x
2026-04-134.32x
2026-04-104.26x
2026-04-094.29x
2026-04-084.42x
2026-04-074.31x
2026-04-064.26x
2026-04-024.23x
2026-04-014.19x
2026-03-314.16x
2026-03-304.06x
2026-03-274.03x
2026-03-264.11x
2026-03-254.10x
2026-03-244.07x
2026-03-234.00x
2026-03-203.93x
2026-03-193.98x
2026-03-183.96x
2026-03-173.97x
2026-03-163.98x
2026-03-133.90x
2026-03-123.82x
2026-03-113.95x
2026-03-103.87x
2026-03-094.11x
2026-03-064.08x
2026-03-054.05x
2026-03-044.13x
2026-03-034.17x
2026-03-024.17x
2026-02-274.22x
2026-02-264.13x
2026-02-254.11x
2026-02-244.07x
2026-02-234.05x
2026-02-204.00x
2026-02-194.04x
2026-02-184.12x
2026-02-174.03x
2026-02-134.35x
2026-02-124.23x
2026-02-114.28x
2026-02-104.23x
2026-02-094.33x
2026-02-064.33x
2026-02-054.02x
2026-02-044.12x
2026-02-034.01x
2026-02-024.12x
2026-01-304.01x
2026-01-294.04x
2026-01-284.10x
2026-01-274.18x
2026-01-264.19x
2026-01-234.11x
2026-01-224.31x
2026-01-214.44x
2026-01-204.35x
2026-01-164.52x
2026-01-154.87x
2026-01-144.79x
2026-01-134.73x
2026-01-124.75x
2026-01-094.80x
2026-01-084.79x
2026-01-074.85x
2026-01-064.89x
2026-01-054.86x
2026-01-024.81x
2025-12-314.79x
2025-12-304.82x
2025-12-294.80x
2025-12-264.78x
2025-12-244.82x
2025-12-234.83x
2025-12-224.79x
2025-12-194.75x
2025-12-184.68x
2025-12-174.68x
2025-12-164.64x
2025-12-154.73x
2025-12-124.66x
2025-12-114.75x
2025-12-104.65x
2025-12-094.63x
2025-12-084.68x
2025-12-054.88x
2025-12-044.91x
2025-12-034.95x
2025-12-024.75x
2025-12-014.77x
2025-11-284.83x
2025-11-264.83x
2025-11-254.89x
2025-11-244.77x
2025-11-214.72x
2025-11-204.48x
2025-11-194.49x
2025-11-184.53x
2025-11-174.57x
2025-11-144.55x
2025-11-134.64x
2025-11-124.77x
2025-11-114.83x
2025-11-104.80x
2025-11-074.72x
2025-11-064.79x
2025-11-054.94x
2025-11-045.00x
2025-11-034.87x
2025-10-314.91x
2025-10-304.85x
2025-10-294.96x
2025-10-284.94x
2025-10-275.01x
2025-10-245.19x
2025-10-235.36x
2025-10-225.05x
2025-10-215.09x
2025-10-205.01x
2025-10-174.93x
2025-10-164.87x
2025-10-154.79x
2025-10-144.76x
2025-10-134.78x
2025-10-104.77x
2025-10-094.80x
2025-10-084.88x
2025-10-074.85x
2025-10-064.88x
2025-10-034.97x
2025-10-024.98x
2025-10-014.95x
2025-09-304.78x
2025-09-294.74x
2025-09-264.76x
2025-09-254.63x
2025-09-244.74x
2025-09-234.57x
2025-09-224.59x
2025-09-194.64x
2025-09-184.64x
2025-09-174.67x
2025-09-164.71x
2025-09-154.69x
2025-09-124.62x
2025-09-114.81x
2025-09-104.65x
2025-09-094.59x
2025-09-084.61x
2025-09-054.57x
2025-09-044.51x
2025-09-034.53x
2025-09-024.44x
2025-08-294.50x
2025-08-284.47x
2025-08-274.48x
2025-08-264.45x
2025-08-254.50x
2025-08-224.51x
2025-08-214.42x
2025-08-204.49x
2025-08-194.50x
2025-08-184.42x
2025-08-154.48x
2025-08-144.48x
2025-08-134.48x
2025-08-124.37x
2025-08-114.37x
2025-08-084.39x
2025-08-074.38x
2025-08-064.32x
2025-08-054.35x
2025-08-044.34x
2025-08-014.35x
2025-07-314.35x
2025-07-304.54x
2025-07-294.61x
2025-07-284.70x
2025-07-254.80x
2025-07-245.09x
2025-07-234.56x
2025-07-224.39x
2025-07-214.21x
2025-07-184.23x
2025-07-174.44x
2025-07-164.50x
2025-07-154.43x
2025-07-144.50x
2025-07-114.56x
2025-07-104.60x
2025-07-094.54x
2025-07-084.42x
2025-07-074.44x
2025-07-034.46x
2025-07-024.44x
2025-07-014.46x
2025-06-304.39x
2025-06-274.39x
2025-06-264.39x
2025-06-254.43x
2025-06-244.46x
2025-06-234.34x
2025-06-204.33x
2025-06-184.37x
2025-06-174.37x
2025-06-164.50x
2025-06-134.45x

Showing the most recent 260 of 5,032 data points. The chart above shows the full history.

About West Pharmaceutical Services, Inc.

West Pharmaceutical Services, Inc. (WST) specializes in the development, manufacturing, and global distribution of essential containment and delivery solutions for injectable pharmaceuticals and other healthcare products. The company's operations span across the Americas, Europe, the Middle East, Africa, and the Asia Pacific region, structured into two primary business units: Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers a comprehensive array of components for injectable packaging, including stoppers and seals, alongside syringe and cartridge parts, which can be customized for specific injectable drug delivery requirements. It also provides advanced drug administration systems designed to enhance safe and effective delivery through sophisticated reconstitution, mixing, and transfer technologies. This segment further supplies ancillary services such as specialized films, protective coatings, cleaning, precision vision inspection, and sterilization processes to elevate the quality of packaging components. Innovative drug containment options, like Crystal Zenith – a cyclic olefin polymer used in vials, syringes, and cartridges – and user-friendly self-injection devices are also key offerings. Additionally, it provides a suite of integrated support services covering analytical laboratory analysis, primary packaging assistance during the pre-approval stage, engineering development, regulatory guidance, and post-purchase technical support. Its clientele primarily includes manufacturers of biologic, generic, and other pharmaceutical products. In contrast, the Contract-Manufactured Products division focuses on the design, production, and automated assembly of various devices for surgical, diagnostic, ophthalmic, and general drug delivery applications, alongside consumer items. This segment caters to pharmaceutical, diagnostic, and medical device manufacturers. The company's offerings reach customers worldwide through a dedicated sales team, an extensive distribution network, and partnerships with contract sales agents and regional distributors. Established in 1923, West Pharmaceutical Services, Inc. is headquartered in Exton, Pennsylvania.

Exton, PA
10,600 employees
Healthcare / Medical - Instruments & Supplies
Sector
Healthcare
Industry
Medical - Instruments & Supplies
CEO
Eric Green